Neurocrine Biosciences Stock Forecast
Neurocrine Biosciences stock price up 0.711% on Monday
(Updated on May 06, 2024)
The Neurocrine Biosciences stock price gained 0.711% on the last trading day (Monday, 6th May 2024), rising from $140.71 to $141.71. During the last trading day the stock fluctuated 2.15% from a day low at $140.55 to a day high of $143.57. The price has been going up and down for this period, and there has been a 6.02% gain for the last 2 weeks. Volume fell on the last day by -131 thousand shares and in total, 474 thousand shares were bought and sold for approximately $67.15 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.90% during the next 3 months and, with a 90% probability hold a price between $138.28 and $152.24 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NBIX Signals & Forecast
The Neurocrine Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $139.67 and $138.12. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -0.92%. Further fall is indicated until a new bottom pivot has been found.
A sell signal from a double top formation was found on Wednesday, May 01, 2024 and based on theory for this formation the price should fall by -12.23% to $124.39 within 28 trading days since signal was issued (Tuesday, May 07, 2024).
Support, Risk & Stop-loss for Neurocrine Biosciences stock
Neurocrine Biosciences finds support from accumulated volume at $140.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $3.01 (2.15%) between high and low. For the last week, the stock has had daily average volatility of 3.21%.
Our recommended stop-loss: $136.73 (-3.51%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (NBIX) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Neurocrine Biosciences to open at $141.94, and during the day (based on 14 day Average True Range), to move between $137.52 and $145.90, which gives a possible trading interval of +/-$4.19 (+/-2.95%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 5.91% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $141.80 (0.06%) than the support at $140.09 (1.14%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Neurocrine Biosciences stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Neurocrine Biosciences stock to perform well in the short-term.
Current score: 2.848 Buy Candidate Unchanged
Predicted Opening Price for Neurocrine Biosciences of Tuesday, May 7, 2024
| Fair opening price May 7, 2024 | Current price |
|---|---|
| $141.94 ( 0.163%) | $141.71 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NBIX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 144.96 | 2.29 % | |
| R2 | 143.80 | 1.48 % | ||
| R1 | 143.09 | 0.98 % | ||
| Current price: | 141.71 | |||
| Support | S1 | 140.79 | -0.649 % | |
| S2 | 140.08 | -1.15 % | ||
| S3 | 138.93 | -1.96 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 143.74 | 1.43 % | |
| R2 | 143.03 | 0.93 % | ||
| R1 | 141.80 | 0.0635 % | ||
| Current price | 141.71 | |||
| Support | S1 | 140.09 | -1.14% | |
| S2 | 136.29 | -3.82% | ||
| S3 | 133.84 | -5.55% |
FAQ
Click here for our free guide on how to buy Neurocrine Biosciences Stock.
